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ABSTRACT  Extracellular matrix (ECM), prepared from chick embryo fibroblasts, contains fibro- 
nectin  as  the  major  structural  protein  along  with  collagen and  other  polypeptides  as  less 
abundant  protein components.  When  Rous sarcoma virus-transformed  chick  embryo fibro- 
blasts are cultured  on the ECM in the presence of the tumor promoter tetradecanoyl  phorbol 
acetate, the transformed  cells lose their characteristic  rounded  morphology and align on and 
within the ECM fibrillar  network. This restrictive  aspect of ECM is only temporary,  however, 
and  with  time  (24-72  h)  the  transformed  cells progressively  degrade the  ECM  fibers  and 
resume their rounded appearance. The matrix degradation  can be monitored by employing 
biosynthetically  radiolabeled  ECM. The addition  of purified  chicken  plasminogen to the Rous 
sarcoma virus-transformed  chick  embryo fibroblast  cultures enhances the rate and extent of 
ECM  degradation,  due  to  the  elevated  levels in  the  transformed  cultures  of  plasminogen 
activator.  Plasminogen-dependent  and -independent degradation of ECM has been character- 
ized with regard to sensitivity to various natural and synthetic  protease inhibitors  and to the 
requirement of celI/ECM contact. Plasminogen-dependent  degradation of ECM occurs rapidly 
when ECM and cells are in contact  or separated, whereas plasminogen-independent  degra- 
dation  is greatly reduced when ECM and cells are separated, which suggests that cell surface- 
associated proteolytic  enzymes are involved.  A possible role in  ECM degradation  has been 
indicated  for cysteine  proteases, metallo  enzymes, and  plasminogen activator,  the  latter as 
both a zymogen activator and a direct catalytic mediator. 
Extracellular matrix (ECM)' is a complex network of proteins 
and carbohydrate polymers that underlies epithelial cells and 
encompasses the cells of the connective tissue.  The compo- 
nents  of the  matrix,  which  include  fibronectin,  collagen, 
elastin,  glycosaminoglycans, and  various  glycoproteins,  are 
synthesized by cells and after secretion are organized into a 
stable  fibrillar  array  (for  review  see  references  1  and  2). 
Abbreviations used in this paper: a2M, alpha-2 macroglobulin; CEF, 
chick embryo fibroblast; ECM, extracellular matrix; FCS, fetal calf 
serum;  MEM, Eagle's minimum essential medium; NPGB, p-nitro- 
phenyl  guanidino  benzoate;  PA. plasminogen  activator;  RSVCEF, 
Rous sarcoma virus-transformed  CEF; TPA. tetradecanoyl  phorbol 
acetate. 
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Although the ECM is essential for structural integrity of the 
tissue,  it  does  not  appear  to  be  an  inert  scaffolding but  a 
molecular complex  that  can  regulate  proliferation,  cellular 
differentiation, and morphogenetic movement (1, 2). A struc- 
tural facsimile of ECM can be produced in vitro by various 
cultured cells including fibroblasts and muscle, epithelial, and 
endothelial  cells (3-10).  The  ECM  produced by these  cells 
has  been  shown  to  have  a  pronounced  effect  on  cellular 
morphology,  adhesion,  locomotion,  proliferation,  and  re- 
sponse to  exogenous effector molecules such  as  hormones, 
growth factors, and enzymes (1 l-15). 
The ECM, which is often adhesive and restrictive in nature 
as it anchors and enmeshes resident cells, appears to be altered 
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imposed  restriction  by  modifying  and  breaking  down  the 
matrix network in vivo. This is often observed in histological 
sections of tumor tissue as "tongues" of malignant cells clear- 
ing away ECM  and penetrating  surrounding normal tissue 
(16). As an experimental model for this process a number of 
investigators have cultured malignant cells on ECM in vitro 
and observed that the cells actively clear the ECM by solubi- 
lizing and degrading the matrix components (17-22).  How- 
ever, a  number of laboratories also have demonstrated that 
when malignant cells are cultured on ECM, the matrix, or its 
individual  components,  imposed  morphological  and  loco- 
motory restriction on the cells, causing them to adhere firmly 
and align on and within the ECM network (9, 23-26). These 
apparent experimental contradictions may be related to the 
nature of the malignant ceils being examined, the histological 
origin  of the  ECM  employed  as  the  substratum,  and  the 
biological  and temporal  limitations of the different experi- 
mental approaches. 
We  have  been  using  normal  chick  embryo  fibroblasts 
(CEFs) and Rous sarcoma virus-transformed chick embryo 
fibroblasts (RSVCEFs) to examine the role of specific proteo- 
lytic enzymes in  modulating the behavior of the RSVCEF 
transformants (27-32).  Normal  CEFs  have been  shown to 
produce an abundant ECM (5), which may have a direct effect 
on the  morphology and  behavior of CEF cultures and  the 
transformants that arise after infection of the CEFs with RSV. 
Therefore we were interested in examining the effect of ECM, 
isolated from cultures of normal CEFs, on homologous cul- 
tures  of  RSVCEFs,  and  in  determining  the  effect  of the 
elevated levels of RSVCEF proteolytic enzymes on such mat- 
rices. Our results indicate that ECM initially has a pronounced 
restrictive effect on the behavior of the transformants but that 
in  time  the transformed cells  overcome that  restriction by 
catalytically degrading the ECM  using a  number of enzyme 
systems. 
MATERIALS  AND  METHODS 
Cell Cultures:  Primary CEFs were prepared from I  0-12<1 old embryos 
(33). The cultures were grown in Eagle's minimal  essential medium (MEM) 
containing  high glucose, penicillin, and streptomycin  and supplemented  with 
10%  heat-inactivated  fetal calf serum (FCS). CEF secondary  cultures  were 
infected  and  transformed  with  RSV  as  described  previously  (27, 28). All 
experiments  were performed  on second, third, and fourth passage cultures of 
CEFs and RSVCEFs. 
Preparation of ECM:  Trial  preparations  of ECM  were carried  out 
according to a number of different methods (9,  18, 20, 34). The method  used 
for all preparations  was a modification  of the procedures described by Jones 
and De Clerk (18). Petri dishes were seeded with CEFs (4 x  10  ~  cells in 35-mm 
dishes) and incubated  in MEM supplemented  with  10%  FCS in the presence 
or absence of ascorbic acid (50 ~g/ml) added  fresh daily. When  the cultures 
reached  confluence  they  were  washed  once  with  phosphate-buffered  saline 
(PBS) deficient  in  calcium  and  magnesium  containing  5  mM  EDTA  and 
incubated in the same solution for 10 min at 37"C. The partially detached cells 
were  lysed away  from  the  underlying  ECM  by  a  wash  and  two  10-rain 
incubations  with  0.025 M  NH4OH  at  room  temperature.  The  ECM  and 
remaining  material  was  washed  twice  with  PBS  deficient  in  calcium  and 
magnesium. The matrices, still firmly attached to the petri dishes, were sterilized 
with 70% ethanol for 10-15 min, stored in PBS at 4°C, and used for experiments 
within  1 wk. 
Radiolabeling  of ECM:  1-2  d  after  CEFs  were seeded when  the 
cultures were 50-75%  confluent,  I3~S]methionine  (10 uCi/ml) was introduced 
to the cultures in fresh medium containing one-twentieth of the normal MEM 
concentration  of methionine.  When the cultures  had  reached confluence  the 
matrices were prepared as described above. 
Treatmerlt of ECM:  Radiolabeled preparations of ECM were washed 
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in PBS and incubated  under one of the following conditions.  Condition  A:  1 
ml  of 5  mM CaCI2, 10  mM N-ethylmaleimide,  50  mM Tris-HCI, pH  7.5, 
containing  260 U collagenase for 1 h at 37"C. Collagenase activity was termi- 
nated by the addition  of 10 mM EDTA. Condition  B:  1 ml of 100 mM Tris- 
HC1, pH 8.0, containing 0.25 #g trypsin for I h at 37"C. Trypsin activity was 
terminated  by the addition  of 5/~g soybean trypsin inhibitor.  Condition  C:  1 
ml trypsin  under incubation  condition  B for  I  h, termination  with soybean 
trypsin inhibitor, wash with PBS, addition of I ml eollagenase under incubation 
condition ,4 for 1 h, and termination  with EDTA. After each enzyme treatment 
the radioactivity released from the ECM was determined  (see below), and the 
residual ECM was solubilized and analyzed by PAGE (see below). 
ECM  Degradation Assay:  Radiolabeled  ECM  preparations  were 
washed with MEM before cells (CEFs or RSVCEFs) were seeded onto them at 
1.5 ×  106 cells/35-mm dish in MEM containing 5% plasminogen-depleted FCS 
prepared as previously described (35). Approximately 18-24 h later the cultures 
were washed with MEM and incubated in 2 ml serum-free MEM in the presence 
or absence of 100 ng/ml of tetradecanoyl  phorbol acetate (TPA). At selected 
intervals thereafter triplicate representative dishes were taken for analysis. The 
supernatant  was removed, phenylmethylsulfonyl fluoride was added to a final 
concentration  of 2 mM, and a 200-ul aliquot was mixed with 5 ml Aquasol-2 
and counted in a beta-liquid  scintillation counter. The remaining supernatant 
was frozen  for later analysis or dialyzed and lyophilized in  preparation  for 
PAGE  (see below). The  remaining  ECM  and  cells were collected  from  the 
dishes by scraping in  0.5  ml  1%  SDS. A  50-~1 aliquot  was added  to 5 ml 
Aquasol-2 and counted in a beta-liquid  scintillation counter. The total counts 
per minute in the  supernatant  and residual matrix  were calculated, and the 
percent radioactivity released was based on counts per minute in supernatant/ 
total  counts per minute  in  supernatant  +  matrix  x  100. The  amount of 
radiolabeled protein  in the matrix and released into the supernatant  was also 
quantitated  by ice-cold 5% trichloroacetic acid (TCA) precipitation of protein 
onto Millipore HF l-in filter disks (Millipore Corp., Bedford, MA). The disks 
were dried under a heat lamp, placed into 5 ml Aquasol-2, and counted  in a 
beta-liquid  scintillation counter. 
Preparation of ECM for Separation and Cell Contact Deg- 
radation Studies:  ECM  was prepared  on  35-mm  dishes  as  described 
above. The vertical sides of the dishes were cut away from the base, leaving the 
ECM intact on a plastic 35-ram disk, which was sterilized in 70% ethanol and 
air-dried. Under these conditions, surface tension allowed the plastic disk to be 
floated on medium with the ECM facing downward in a 60-ram culture dish 
1-2  mm above a monolayer  of cells. Alternatively, the plastic disk could be 
rewetted with medium and submerged on the bottom of a 60-ram culture dish 
with the ECM facing upward. A cell suspension was added to the dish, allowing 
the ceils to attach directly to the ECM. 
5D5  PAGE:  Samples of supernatant  and  resuspended  matrices  were 
mixed with appropriate volumes of concentrated  electrophoresis sample buffer 
(36) containing 5% beta-mercaptoethanol,  boiled, and applied directly on 8.5% 
polyacrylamide  slab  gels using  the  system  of Laemmli  (36). Alternatively, 
samples were dialyzed against 500 vol 0.01% SDS, lyophilized, and taken  up 
in electrophoresis sample buffer containing  5% beta-mercaptoethanol,  boiled, 
and analyzed on 8.5% polyacrylamide slab gels. Unless otherwise noted, equal 
volumes of  supernatant and equal volumes ofresuspended matrices correspond- 
ing to one culture dish or an equal fraction thereof were applied onto the gels. 
After electrophoresis, the gels were stained in 0.25% Coomassie Blue in 50% 
methanol, 8% acetic acid for 1-2 h at 37"C and destained with several changes 
of 5%  methanol,  12%  acetic acid. Autoradiography  was performed  on gels 
containing  35S-labeled proteins  with  Kodak  R  film,  Ready  pack. Molecular 
weight standards were run in parallel lanes and included myosin (200,000), B- 
galactosidase (135,000), bovine serum albumin (67,000), ovalbumin  (43,000), 
chymotrypsinogen (25,000), and cytochrome c (12,000). 
Microscopy:  Cells  cultured  on  matrices  that  had  been  prepared  on 
strips (6  x  20  ram) of tissue culture  plastic cut from  Lax  petri dishes (Lux 
Scientific Inc., Newbury Park, CA) were fixed with 1.5% glutaraldehyde in 0.1 
M potassium  phosphate,  pH 7.4, for 1 h and washed overnight at 4*(" in the 
phosphate buffer. Fixed samples were prepared  for scanning electron  micros- 
copy by critical point drying, coated with evaporated gold, and examined with 
a JEOL 100C electron  microscope in the scanning mode. Samples for phase 
microscopy  were examined  with  an  inverted  phase  microscope  and  photo- 
graphed  with a Polaroid  camera.  ECM-containing  dishes were prepared  and 
analyzed for immunofluorescence  using an anti--chicken fibronectin antiserum 
(37, 38). 
Preparation of Plasminogen, Plasminogen-free  Serum, and 
Acid-treated Serum:  FCS and chicken serum  were selectively  freed of 
plasminogen by two passages  over a lysine-Sepharose affinity column according 
to established procedures (35). The serum was assayed with purified plasmin- 
ogen activator (PA) (39) and shown to be 95-100% plasminogen free. Plasmin- 
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acid  in  PBS containing  5  mM  EDTA.  The plasminogen  was judged  to be 
homogeneous  by  SDS PAGE  and was resolved as a  single protein  band at 
95,000 D. Acid-sensitive protease inhibitors in serum were inactivated by the 
addition  of 1 N  HCI to serum, bringing the pH to 3.0-3.5.  The serum was 
incubated  at room temperature  for 2 h and reneutralized  to pH 7.4 with the 
addition of I N NaOH. This procedure destroys ~90% of  the protease inhibitory 
capacity of FCS (40). 
PA Assa y:  PA activity was based on the plasmin-mediated hydrolysis of 
~251 fibrin and measured  as described previously (27-30).  1 U PA activity is 
equivalent to the release of 2,000 cpm t251 in 2 h at 37°C in the presence of 5 
lag purified chicken plasminogen. Fibrin, free of plasminogen, was prepared as 
previously described (41 ). 
Materials:  Human alpha-2 macroglobulin (a2M)  was provided by Dr. 
Richard Feinman (Downstate Medical Center). Chicken myosin and actin were 
provided by Dr. Alfred Stracher (Downstate Medical Center). A preparation of 
chicken procollagen/collagen was provided by Dr. Bjorn Olsen (Rutgers Med- 
ical School,  New Brunswick, NJ).  Na-125I (carrier-free) and  [~SS]methionine 
(700-1400  Ci/mmol)  were  purchased  from  Amersham  Corp.  (Arlington 
Heights, IL). TPA was purchased from Chemical Carcinogenesis (Eden Prairie, 
MN). Chick embryonated eggs (Cofal negative) were obtained from Spafas, Inc. 
(Norwich, CT). FCS was purchased from Hyclone Laboratories, Sterile Systems, 
Inc. (Logan, UT). Collagenase type 111 was purchased from Advance Biofactors 
(Lynbrook, NY). Aquasol-2 was purchased  from New England Nuclear (Bos- 
ton,  MA). Trasylol,  1,10 phenanthroline,  leupeptin,  and p-nitro-phenylguani- 
dino benzoate (NPGB) were purchased  from Sigma Chemical Co. (St. Louis, 
MO). E64c was provided by Dr. Joseph Etlinger (Downstate Medical Center). 
RESULTS 
Preparation and Characterization of ECM from 
Monolayer Cultures of CEFs 
Growing cultures of CEFs were incubated with [35S]methi- 
onine  to  radiolabel  the  protein  components  of the  ECM. 
When ECM is prepared from radiolabeled CEF cultures that 
have been grown in the presence and absence of ascorbic acid 
(50 tzg/ml) the matrix preparations are qualitatively similar, 
with some quantitative differences due to increases in procol- 
lagen-like molecules (Fig.  1A). Fibronectin is the major poly- 
peptide of both preparations, composing >75%  of the total 
radiolabeled polypeptides (as determined by densimetric scan- 
ning). Matrices prepared from ascorbic acid-treated cultures 
exhibit an increase in two sets of polypeptide doublets corre- 
sponding to apparent molecular weights of 145,000/155,000 
and  180,000/185,000,  which  co-migrate with a  preparation 
of chicken type I procollagen/collagen. Treating this matrix 
with collagenase releases only 3-4% of the total radioactivity, 
and  the  resulting  ECM  polypeptide  pattern  appears  un- 
changed (Fig.  i B,  lane 2).  Trypsin treatment, however, re- 
leases 50-60%  of the total radioactivity, removing most of 
the fibronectin and some of the procollagen/collagen bands 
(Fig.  1  B, lane 3). If  the trypsin-treated ECM is then incubated 
with collagenase, 5-10% of the original total radioactivity is 
released and the  150K and  180K bands are removed (Fig. 
1  B, lane 4). These results indicate that whereas fibronectin is 
the  major protein  of ECM,  collagen  components  are  less 
abundant  proteins and  can only be released by collagenase 
after the  removal of fibronectin and  other trypsin-sensitive 
glycoproteins. 
Indirect immunofluorescence with an antibody to fibronec- 
tin illustrates that the fibrillar arrays of the ECM stain heavily 
for fibronectin (data not shown), which is consistent with the 
dominance of fibronectin shown in  the  polyacrylamide gel 
pattern of Fig.  1 and similar to that reported by Chert et al. 
(5). 
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FIGURE  I  ECM prepared from cultures grown in the presence and 
absence of ascorbate: effect  of trypsin  and collagenase treatment. 
(A)  Autoradiograph of  radiolabeled ECM  polypeptides prepared 
from CEF cultures that had been incubated in the absence (lane I ) 
or presence (lane 2) of 50/~g/ml of ascorbic acid for 48 h before 
preparation of the ECM. (B) Autoradiograph of radiolabeled ECM 
polypeptides prepared from  ascorbic  acid-treated cultures.  The 
ECM preparations were incubated for 1 h at 37°C in buffer alone 
(lane 1  ), buffer plus 260 U collagenase (lane 2), buffer plus 0.25 #g 
trypsin  (lane 3), and  buffer plus trypsin  (0.25 u.g) for  1 h  before 
collagenase (260 U) was added for 1 h (lane 4). The ECM was then 
prepared for SDS PAGE  and autoradiography.  Marker proteins were 
run in a parallel lane of the gels, and their positions are indicated. 
In  /3  overexposure of the  autoradiograph caused  the  145/155K 
doublet to resolve only as a single band at 150K. 
Effect of Chick ECM on the Morphology of 
Transformed Chick Fibroblasts 
It is well  established that when CEFs are transformed by 
RSV their morphology is dramatically altered (42),  and this 
has  been  ascribed  to  the  diminished  production  of ECM 
components by transformed cells (37, 43, 44). It has also been 
shown that treatment of RSVCEF cultures with the tumor 
promoter TPA  causes  pronounced  clustering  of the  trans- 
formed cells  and  a  concomitant loss  of the  residual  ECM 
substratum (28,  29,  45).  When transformed CEFs are incu- 
bated  in  serum-free  medium  on  the  ECM  prepared  from 
normal CEFs,  distinct  morphological changes are  observed 
(Fig.  2).  The transformed cells appear more elongated, less 
refractile, and less randomly oriented (Figs. 2, c and d). More 
striking is the  effect of ECM on the TPA-treated RSVCEF 
cultures. The cell clustering brought about by TPA treatment 
(28, 29) is completely prevented by the presence of the ECM 
(Fig.  2,  e  and f).  The  TPA-treated  RSVCEF  cells remain 
elongated and appear completely aligned on the underlying 
ECM. The inhibitory effect of intact ECM on cell clustering, 
however, is only temporary. If the TPA-treated cultures are 
incubated for an additional 25 h, the ECM appears to be lost 
and the cells become disorganized and eventually cluster (Fig. 
2h). with  or  without  normal  CEFs  since  only  from  5  to  8%, 
respectively, of the labeled material was released during a 48- 
h incubation. RSVCEFs, however, induce a progressive break- 
down  of ECM  components,  releasing  35%  of the  protein 
components after 48  h.  Matrix degradation  is dramatically 
increased by TPA-treated RSVCEF cultures, which released 
40% of the radioactivity after 24 h and 70% after 48 h. The 
extensive solubilization  of ECM  polypeptides in  the  TPA- 
treated  RSVCEF cultures  correlates with the  extensive cell 
clustering observed in  Fig.  2h.  That the  pattern  of matrix 
degradation was similar for ECM prepared in ascorbate-free 
and ascorbate-containing medium (Fig.  3) indicates that the 
increased collagen deposition did not affect the overall pattern 
of ECM solubilization by the transformed ceils. 
Plasminogen-dependent and -independent 
Degradation of ECM 
The degradation of ECM by transformed cells  in  serum- 
free  medium  observed in  Fig.  3  can  be  enhanced  by  the 
addition  of purified chicken plasminogen (Fig.  4),  and this 
increased  rate  of degradation  is  prevented  by trasylol,  an 
inhibitor of plasmin. This indicates that the elevated levels of 
PA (28) catalytically convert plasminogen to plasmin, which 
in turn rapidly degrades the ECM. Trasylol, however, had no 
effect on the cell-mediated ECM degradation, as 70-80% of 
the  radiolabeled ECM was released over 48  h  in  either the 
presence  or  absence  of trasylol  (Fig.  4).  The  polypeptides 
released from the ECM into the culture medium are shown 
in Fig.  5 and provide evidence that the cell-mediated degra- 
dation  of ECM  is  distinct  from the  plasminogen-mediated 
degradation. The polypeptide pattern of the culture medium 
FIGURE  2  Morphology of normal and transformed cells incubated 
on tissue culture plastic (left) or ECM (right).  Normal CEF (a and b) 
and RSVCEFs (c and d) were seeded (1.5 x  106 cells/35-mm dish) 
in  MEM  containing  5%  plasminogen-depleted FCS  onto  plastic 
tissue culture dishes  or dishes  that contained ECM. After 24 h all 
cultures were washed in  MEM  and  incubation was continued in 
serum-free MEM. Some of the RSVCEF cultures were supplemented 
with TPA (e-h) (100 ng/ml). Phase-contrast photomicrographs  were 
taken 23  (a-f)  or 48 h  (g and h) after the addition of serum-free 
MEM. 
The  PA  activity  of CEFs,  RSVCEFs,  and  TPA-treated 
RSVCEFs  cultured  on  ECM  was 0.46,  12.9, and  81.2  U/ 
culture,  respectively, at  23  h,  which  demonstrates that  the 
substantial increases in PA activity upon RSV transformation 
and TPA treatment (28, 29) are not reversed by culturing on 
ECM. 
Alteration and Degradation of ECM by 
Transformed and TPA-treated Transformed Cells 
Since the  morphological studies  indicated  that the  ECM 
was absent after a 48-h incubation of transformed cultures in 
TPA we decided to quantitate the apparent loss of ECM using 
35S-radiolabeled  matrices. Fig.  3 demonstrates that the ECM 
was relatively stable when incubated in serum-free medium 
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FIGURE  3  Degradation of radiolabeled ECM by normal and trans- 
formed cells. CEFs and RSVCEFs were seeded (1.5 x  106 cells) onto 
35-mm petri dishes containing 3sS-labeled ECM (see Materials and 
Methods).  At  zero  time  (18  h  after  seeding)  the  cultures  were 
washed  with  MEM  and  incubated  in  serum-free  MEM  with  or 
without TPA (100 ng/ml). As controls, dishes containing 3SS-labeled 
ECM were incubated in MEM without cells. At the indicated times 
the medium was removed from the culture dishes and counted for 
radioactivity. The ECM were prepared from CEF cultures grown in 
the absence (solid lines) or presence (dashed lines) of ascorbate. 
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FIGURE  4  Plasminogen  (plg)/plasmin-mediated  degradation  of 
ECM: effect of a plasmin inhibitor and comparison with cell-medi- 
ated,  plasminogen-independent  ECM  degradation.  Cultures  of 
RSVCEFs were incubated in  serum-free medium containing TPA 
(100 ng/ml) on 35-mm dishes containing 35S-labeled ECM. Purified 
chicken plasminogen (2 #g) was added to some of the cultures at 
zero time in the presence or absence of trasylol (20 U/ml). Parallel 
cultures were incubated in the absence of plasminogen but in the 
presence or absence of trasylol. At the indicated times the medium 
was removed and counted for radioactivity. 
FIGURE  5  Autoradiographic analysis of radiolabeled polypeptides 
released  into the culture medium from 35S-labeled ECM. The su- 
pernatant polypeptides from cultures of RSVCEFs incubated in TPA 
plus  plasminogen for  6  h  (/eft) are  compared with the  medium 
polypeptides from parallel cultures of RSVCEFs incubated in TPA 
in  the absence  of plasminogen for 48  h (right).  Equal volumes of 
supernatants  were dialyzed, lyophilized, and  analyzed by  PAGE 
and autoradiography as described in Materials and Methods. 
from a 6-h plasminogen incubation (30-40% release of radio- 
activity) is different from the polypeptide pattern of the cul- 
ture medium from a 48-h incubation of cells on ECM in the 
absence  of plasminogen  (40-50%  release  of radioactivity). 
The gel  patterns shown in  Fig.  5 also indicate that most of 
the ECM proteins are not just released intact from the surface 
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of the culture dish.  Little or no intact fibronectin is present 
in either supernatant. 
When the radioactivity released into the different culture 
supernatants is analyzed by TCA precipitation,  72-93%  of 
the released radioactivity remains acid precipitable. This in- 
dicates  that  most matrix  proteins  are  released  as  partially 
degraded polypeptides, as illustrated in Fig. 5, and not exten- 
sively broken down to acid-soluble peptides and amino acids. 
The radioactivity in untreated, intact matrices is 90-95% acid 
precipitable. The radioactivity released into the culture super- 
natants was also analyzed by Sephadex G100 chromatogra- 
phy: 10-33% of the released radioactivity is found in the void 
volume of the column; 30-66% of the released radioactivity 
is found in the included volume of the column; and only 12- 
27%  is  found  in  the  column  volume that  corresponds  to 
molecular weights <10,000.  Approximately 80-90%  of the 
radioactivity from untreated matrices elutes in the void vol- 
ume. These results further demonstrate that partial degrada- 
tion  of matrix  proteins  occurs  under  the  different  culture 
conditions. 
Effect of Protease Inhibitors  on Cell-mediated 
ECM Degradation 
Using selective protease inhibitors we further examined the 
nature of the cell-mediated, plasminogen-independent degra- 
dation (Fig. 6). The protease inhibitors were added to cultures 
at concentrations that in prior experiments had been shown 
to have no effect on cell viability, cell plating efficiency, and 
cellular protein and RNA synthesis (29).  Diisopropylfluoro- 
phosphate, the general inhibitor of serine proteases (46),  in- 
hibits ECM degradation by RSVCEF cultures to 32-38% of 
control. The epoxide derivative E64c, an inhibitor of mam- 
malian cysteine proteases (47),  inhibits ECM degradation by 
30-43%.  The  metallo-protease inhibitor,  1,10  phenanthro- 
line, inhibits degradation by 40-53%. The combined use of 
all three inhibitors  reduces ECM degradation by 80%  (Fig. 
6A).  NPGB, a  potent inhibitor of arginine-preferring serine 
proteases (31),  inhibits ECM degradation by 35 % (Fig.  7 B), 
a  percent  inhibition  similar to  that  observed for the  more 
general serine protease inhibitor diisopropylfluorophosphate 
(Fig. 6 A). Leupeptin, an inhibitor of arginine-preferring serine 
and thiol  proteases (48),  also inhibits  ECM  degradation to 
37% of control. The combined use of leupeptin and NPGB 
did not alter significantly the inhibition pattern exhibited by 
either compound alone (Fig. 6B). This result is in contrast to 
the combined use of the more general protease inhibitors (Fig. 
6A)  and  suggests  that  a  specific  arginine-preferring  serine 
protease is partially responsible for the degradation of ECM 
by RSV-transformed cells. 
Effect of Serum and Serum Components  on 
ECM Degradation 
All  of the  previously described ECM degradation studies 
were performed in serum-free medium. Since FCS that con- 
tains  plasminogen  (35)  is  a  standard  supplement of trans- 
formed cell cultures, we examined the effect of FCS supple- 
mentation on matrix degradation (Fig. 7). Adding 5% FCS to 
cultures of TPA-treated RSVCEFs incubated on radiolabeled 
ECM increases the degradation of ECM over that of parallel 
cultures incubated in  serum-free medium.  This increase in 
degradation (5 to  15% after 6 h, 40 to 55% after 24 h) is not 6O  A 
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FIGURE  6  Effect of protease inhibitors on the degradation of ECM by transformed cells. Cultures of RSVCEFs were seeded onto 
35-mm dishes containing 35S-labeled ECM.  18 h  later the cultures  w~re changed  into serum-free medium  supplemented with 
TPA (100 ng/ml) and the indicated inhibitors, and the release of radioactivity was measured at the indicated times thereafter. (A) 
The serine protease inhibitor diisopropylfluorophosphate (DFP; 250 ~M), the cysteine protease inhibitor E64c (50 ~,g/ml),  and the 
metallo-protease inhibitor 1,10 phenanthroline (1,10-Ph;  10/~g/ml) were added to individual cultures, and a combination of all 
three  inhibitors at their respective concentrations was added to a separate culture.  A  culture of CEFs served as a control.  (B) 
Protease inhibitors that are arginine analogues, NPGB  (20 ~M) and leupeptin (300/zM) were added separately and together to 
individual cultures. Culture medium without cells served as control. 
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FIGURE  7  The  effect  of 
serum and serum compo- 
nents  on  ECM  degrada- 
tion.  Parallel  cultures  of 
RSVCEFs,  18 h  after seed- 
ing  onto  radiolabeled 
ECM,  were  incubated  in 
medium  supplemented 
with  TPA  (100  ng/ml)  and 
5%  FCS  treated  as  indi- 
cated. After 6 and 24 h the 
release of radioactivity into 
the  supernatant  from  the 
different cultures was mea- 
sured.  The  depletion  of 
plasminogen  from  the 
serum and the inactivation 
of  acid-sensitive  serum 
protease inhibitors are de- 
scribed  in  Materials  and 
Methods. 
as substantial as the increase observed when purified plasmin- 
ogen is added to serum-free cultures (Fig. 4). Since this might 
be due to natural protease inhibitors present in serum, FCS 
was acid treated and reneutralized  to inactivate most of the 
protease  inhibitory capacity of FCS (40).  Acid-treated  FCS 
enhanced the degradation of ECM by RSVCEFs (25%  after 
6  h  and  70%  after 24 h) to levels similar to those observed 
when purified plasminogen was added to serum-free cultures 
(Fig. 4). That the increase in ECM degradation in the presence 
of FCS or acid-treated FCS was dependent on serum plasmin- 
ogen is illustrated by the reduction in ECM degradation that 
occurs when plasminogen-depleted  FCS or plasminogen-de- 
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pleted, acid-treated FCS is used as a supplement (Fig. 7). The 
plasminogen depletion  of FCS  by lysine  Sepharose  affinity 
chromatography  used  in  these  experiments  selectively  re- 
moves >98% of the plasminogen in serum (35). 
ECM Degradation  by Transformed Cells in Direct 
Contact with or Separated from ECM: Effect of 
Plasminogen and the Protease Inhibitor ~2M 
Degradation of ECM  proteins by transformed cells could 
be mediated by cell surface proteolytic enzymes or by secreted 
proteolytic enzymes or both. To examine these possibilities, 
l:xtracellular Matrix Degradation by Transformed Ceils  1795 TABLE  I.  ECM Degradation by Transformed Cells in Direct Contact 
with ECM or Separated from ECM: Effect of Plasminogen and the 
Protease Inhibitor cv2M 
Radioactivity 
Plasmino-  released 
gen  pres  ~,2M 
Conditions  ent  present  4  h  23  h  47  h 
Cells  in  contact with 
matrix 
a  -  -  -  36.0  75.4 
b  -  +  35.7  55.8 
c  +  -  35.8  91.9  >95 
d  +  +  18.3  76.6  >95 
Cells and  matrix sep- 
arated 
e  -  -  8.3  27.7 
f  -  +  3.9  9.3 
g  +  -  21.8  88.2  >95 
h  +  +  2.4  9.9  13.9 
No cells on matrix 
i  -  -  1.1  3.2 
j  +  -  2.3  6.9  -- 
Preparations of radiolabeled  ECM on plastic disks were floated (ECM facing 
downward) in serum-free medium  1  2  mm  above a monolayer of 4  x  106 
RSVCEF cells (separated conditionsj or placed in culture dishes (ECM facing 
upward)  with  4  x  106  RSVCEF cells  seeded  on  top  of the  disks  (contact 
(onditions). TPA (100 ng/ml) was added to all cultures. Some of the cultures 
received 2/~g purified chicken  plasminogen  (lines c, d,  g,  and h) and some 
cultures received 180/~g purified  human  a2M (lines a, d, f, and  h).  Control 
dishes contained  radiolabeled  ECM  in  medium  alone (without cells) in the 
absence or presence of plasminogen  (lines i and/).  At  the indicated  times, 
the culture medium was analyzed for the release of radioactivity as described 
in Materials and Methods. All the cultures were analyzed in triplicate and the 
numbers represent the mean percent radioactivity released with the standard 
deviation <10% of the individual mean values. 
transformed  cells  were  incubated  either  in  direct  physical 
contact with radiolabeled ECM or separated from the ECM. 
We separated cells from ECM by preparing ECM on plastic 
tissue  culture  disks  and  floating  the  disks  in  the  medium 
above a monolayer of RSVCEFs separated from the cells by 
a  distance of 1-2 ram. An equivalent number of RSVCEF 
were plated onto the  ECM disks in  direct contact with the 
ECM in parallel experiments. The results of  these experiments 
are shown in Table I. 
Cells in direct contact with ECM degraded the matrix at a 
relatively slow but progressive rate (Table I, line a) similar to 
that  observed  in  Fig.  4.  When  an  equivalent  number  of 
RSVCEF cells  were separated from the  ECM  a  substantial 
reduction in ECM degradation was observed (Table I, com- 
pare  lines  a  and  e).  This  suggests  that  cell-mediated ECM 
degradation is brought about mainly by cell surface proteases 
or enzymes closely juxtaposed with  the  cell  surface.  When 
plasminogen was added to the cultures (Table I, line c) a rapid 
degradation of ECM occurred under contact conditions, sim- 
ilar to that observed in Fig. 4. A similar rapid ECM degrada- 
tion occurred under separated conditions in the presence of 
plasminogen (Table I, compare lines c and g).  This result is 
consistent with the conversion of plasminogen to plasmin by 
cellular PA,  and plasmin, being soluble and diffusable, can 
rapidly degrade the separated ECM. 
The addition  of a2M  to the cultures further illustrates a 
distinct difference between cell contact-mediated ECM deg- 
radation and ECM degradation by diffusable enzymes. Under 
conditions  of cell/ECM  separation,  c~2M inhibits  cellular 
enzyme-mediated,  plasminogen-independent  degradation 
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(Table I, lines e and f) and substantially inhibits the plasmin- 
ogen-dependent degradation (Table I, lines g and h).  Under 
conditions ofcell/ECM contact, plasminogen-dependent deg- 
radation is partially inhibited by a2M (Table I, lines c and d), 
whereas the cell-mediated, plasminogen-independent degra- 
dation is not inhibited early (23 h) and inhibited only 25% 
later (Table I, lines a and b). The partial inhibition by c~2M 
observed later could be accounted for by c~2M inhibition of 
diffusable cellular enzymes since, in Table I, ~25-30% of the 
degradation  observed in  line  a  is due to diffusable cellular 
enzymes (line e),  which are substantially inhibited  by a2M 
(line JO.  Thus  c~2M, a  broad  spectrum  protease  inhibitor, 
inhibits ECM degradation by the soluble, diffusable enzymes 
generated  by the  transformed cells  but  has  little  effect on 
enzymes closely juxtaposed with the ECM. 
DISCUSSION 
Normal CEFs produce an ECM, highly enriched in fibronec- 
tin, that restricts and alters the behavior of RSVCEFs when 
the  latter  are  cultured  on  the  ECM.  The  RSVCEF  cells 
become enmeshed within the matrix network and lose their 
characteristic rounded refractile and disoriented morphology 
(Fig.  2f).  These results are consistent with the observations 
made by other laboratories that exogenous fibronectin restores 
a more "normal" morphology to transformed fibroblasts (24- 
26).  The present study demonstrates, however, that this res- 
torative ability of ECM components is only shortlived. The 
transformed cells, unlike the normal CEFs, can progressively 
degrade  the  proteins  of ECM  and  thereby  overcome  the 
restrictive properties of the underlying matrix. This is espe- 
cially pronounced when the transformed cells are treated with 
the tumor promoter TPA, which induces a highly transformed 
phenotype (28,  29).  Concomitant  with  matrix degradation, 
the TPA-treated transformed cells regain their abnormal mor- 
phology and migrate or rearrange in culture to form multi- 
cellular clusters (Fig. 2 h). 
The nature of the degradative ability of transformed fibre- 
blasts is complex, but the present study illustrates some aspects 
of their  catalytic activity toward  ECM.  When  a  source  of 
plasminogen is present, the degradation of the ECM is rapid 
and  extensive  (Fig.  4)  due  to  the  conversion  of inactive 
plasminogen to the active protease plasmin by the elevated 
levels of PA  produced by the transformed cells  (29,  30).  If 
serum is present,  RSVCEF-mediated ECM degradation oc- 
curs, but its rate and extent are controlled by the presence of 
acidqabile protease inhibitors in the serum (Fig. 7). The rapid 
clearing of matrix in the presence of serum appears to be due 
mainly to  plasmin  since  selective removal of plasminogen 
from serum reduces ECM degradation to the level observed 
in serum-free medium. This plasminogen dependence in the 
presence of serum was not observed by Kramer et al. (20) in 
studies on endothelial ECM degradation by B i6  melanoma 
cells.  However, studies from other laboratories that demon- 
strated degradation of  endothelial ECM by highly tumorigenic 
fibrosarcoma cells (18) and lung tissue matrix degradation by 
metastatic tumor cells (21) indicate that serum plasminogen 
is involved in transformed cell-mediated matrix degradation. 
The present studies also demonstrate that a plasminogen- 
independent  ECM degradation can occur.  This degradation 
is not as rapid as plasmin-dependent degradation, but,  it is 
progressive, and eventually all or most of the ECM present in 
a culture dish is solubilized (Fig. 4). Although such plasmin- ogen-independent degradation has been observed by several 
laboratories that employed various tumor cells (20-22),  the 
enzymatic nature of the process remained unresolved. In the 
CEF/RSVCEF  culture systems described  herein, certain  as- 
pects of the process have been resolved. First, the process is 
mediated  by  cellular  enzymes  distinct  in  specificity  from 
plasmin since it is completely insensitive to trasylol (Fig.  4) 
and the polypeptide patterns of solubilized components are 
distinct from plasmin-mediated degradation patterns (Fig. 5). 
Second,  the  cell-mediated degradation  of ECM  is  partially 
sensitive to a  few selective inhibitors  of arginine-preferring 
serine proteases (Fig, 6 B). However, partial sensitivity to these 
inhibitors suggests  that a  number of other types of cellular 
enzymes also are active in ECM degradation. The sensitivity 
of ECM  degradation  to E64c  and  1,10  phenanthroline,  re- 
spectively, (Fig.  6A) suggests  that cysteine and  metallo-pro- 
teases are directly involved in matrix degradation. The iden- 
tity of these proteolytic enzymes is unresolved, but Chen et 
al.  (49)  observed that  clearing of fibronection spots at cell 
substratum contact sites was inhibited by  1,10  phenanthro- 
line,  which  supports the  involvement of a  transformation- 
associated metallo-protease. 
These studies suggested the identity of the arginine-specific 
protease(s). Previous studies (29)  from this laboratory have 
indicated that the distinct morphological alterations that oc- 
cur in TPA-treated RSVCEF cultures are mediated in part by 
the direct catalytic activity of PA, an arginine-preferring serine 
protease. The PA activity in  this culture  system is elevated 
upon TPA treatment (28),  is found associated with a plasma 
membrane-like fraction (27),  and is sensitive to diisopropyl- 
fluorophosphate,  NPGB,  and  leupeptin  but  insensitive  to 
trasylol (29). These results are consistent with a direct catalytic 
role for PA independent ofplasminogen in ECM degradation. 
Conclusive proof,  however,  that  PA  can  directly hydrolyze 
matrix  proteins must await studies with  specific antibodies 
that inhibit the catalytic activity of PA. Such experiments are 
under investigation. 2 
A major part of the cell-mediated, plasminogen-independ- 
ent ECM degradation requires close contact between cells and 
ECM  (Table  I).  These  results suggest  that  cell-surface pro- 
tease(s) or secreted protease(s) in close apposition to the cell 
surface are involved in ECM degradation. Recent studies from 
other laboratories have indicated  that  ECM degradation by 
mouse  trophoblasts  (50)  and  virus-transformed  fibroblasts 
(49)  is  highly  localized  and  appears to  occur at  cell/ECM 
contact sites.  Studies by Mahdavi and Hynes (51) have also 
indicated  that  close contact  between  transformed, cells and 
normal cells was required to degrade the fibronectin present 
on the normal cells.  When  the cell types were separated by 
short distances little or no loss of fibronectin occurred. 
The ECM degradation that occurs when RSVCEF cultures 
are in direct contact with the matrix is insensitive to the serum 
protease inhibitor a2M.  The a2M is a broad spectrum pro- 
tease inhibitor that  inhibits all  known  proteolytic enzymes 
(52) including RSVCEF plasminogen activator (unpublished 
observations). The inability of this  molecule to inhibit  cell 
contact-mediated  ECM  degradation  suggests  that  a2M,  a 
large  molecular weight  protein,  cannot  gain  access  to  the 
protease(s) operating at close ECM/cell contact points. ECM 
2 Matrix degradation by RSVCEF is inhibited 35-50% by a highly 
specific monoclonal antibody directed against avian PA (manuscript 
in preparation). 
degradation that occurs when cells and ECM are separated, 
mediated either by plasmin or proteases secreted by cells, is, 
in contrast, highly sensitive to a2M (Table I). Thus, the cell- 
mediated  degradation  of ECM  by malignant  cells  at  close 
contact  points  is  more  insidious  since  it  can  occur in  the 
virtual absence of serum and plasminogen and is refractory 
to control by natural protease inhibitors such as trasylol and 
a2M. 
The study of ECM degradation  by cultured  transformed 
cells can serve as a model system for tumor cell invasion and 
can  also  indicate  specific enzymes and  classes  of enzymes 
involved in matrix degradation, but the model has a number 
of limitations. The ECM prepared from cultured fibroblasts 
may  not  be  totally  representative  of the  connective  tissue 
matrix  that  is  laid down  in  vivo.  In the  present  study the 
ECM produced by embryonic chick fibroblasts is composed 
mainly of fibronectin and contains relatively less collagen and 
other connective tissue components. However, studies from 
Liotta's laboratory have clearly indicated that collagen break- 
down is an important aspect of tumor cell invasion (17,  53, 
54),  and reports by Kramer et al. and Nakajima et al.  have 
shown that degradation of matrix proteoglycans is character- 
istic of the invasive capacity of a tumor cell (20,  55). Thus, a 
fibronectin-enriched,  embryonic fibroblast matrix  is only a 
limited model system for studying malignant cell  invasion. 
Nevertheless, the present study, employing a homologous cell 
system of transformed chick cells cultured on normal chick 
ECM, has indicated that elevated levels of PA in transformed 
cells can bring about a rapid degradation of fibronectin and 
other matrix proteins through the generation of plasmin. In 
the  absence of plasminogen, the transformed cells can  use 
their locally secreted and surface enzymes, including possibly 
the direct catalytic action of PA to bring about a progressive 
degradation of matrix in the immediate vicinity of the cells 
even in the presence of natural protease inhibitors. Once the 
matrix under and around the cells  has been solubilized,  its 
adhesive and  restrictive aspect is thus  eliminated,  releasing 
the maligant cells to continue along their migratory, degra- 
dative, and invasive pathway, 
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